Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01543217 · ClinicalTrials.gov registry record · NA
Respiratory Disease Management
A NA study, sponsored by Barnes-Jewish Hospital.
- Completed
- Registry status
- NA
- Development phase
- 428
- Enrollment target
NCT01543217: Completed NA study, sponsored by Barnes-Jewish Hospital.
NCT01543217 is a NA study that has completed, run by Barnes-Jewish Hospital. The registered enrollment target is 428 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01543217, a NA study, has completed, sponsored by Barnes-Jewish Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 428 participants
- Enrollment target
Study Summary
The aim of this study is to reduce the number of subsequent hospital admissions and/or emergency department (ED) visits for hospitalized patients with chronic obstructive pulmonary disease (COPD) by utilizing a respiratory care practitioner-led disease management (RCP-DM) program compared to standard discharge instructions and planning.
Primary Outcome
Coordinators will use two strategies, First, they will monitor the automated medical record. All inpatient, outpatient, and ED visits to BJC affiliated institutions. Second coordinators will conduct bi-monthly telephone inquires to patients to determine if they had recent hospital or ED visits.
Interventions
- OTHER RT management
- OTHER Ususal care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 428 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT01543217 record still lists
NCT01543217 is an interventional study that assigns participants to a tested intervention. The registered 428 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (70% lower).
The record links to 0 conditions, and to 2 interventions - of which RT management is the first listed.
NCT01543217 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01543217 about?
NCT01543217 is a clinical study titled "Respiratory Disease Management". The aim of this study is to reduce the number of subsequent hospital admissions and/or emergency department (ED) visits for hospitalized patients with chronic obstructive pulmonary disease (COPD) by utilizing a respiratory care practitioner-led disease management (RCP-DM) program compared to standar...
What is the current status of trial NCT01543217?
This trial is currently completed. It is a NA study. The enrollment target is 428 participants. The study started on 2012-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01543217?
The interventions under investigation include: RT management (OTHER), Ususal care (OTHER).
Who is sponsoring clinical trial NCT01543217?
This trial is sponsored by Barnes-Jewish Hospital, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01543217's enrollment target sits among peer trials
428 236th of 2000 higher than 1,765 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05566431 · 428 participants · NA
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
- NCT05646316 · 428 participants · Phase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- NCT05797610 · 428 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- NCT06073626 · 428 participants · NA
Addressing Genomic Disparities in Cancer Survivors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia